Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old-fashioned” Drug be Effective?

• Marta Riva,
• Alessandro Bosi,
• Lorenzo Rizzo,
• Federico Mazzon,
• Silvia Ferrari,
• Federico Lussana,
• Lorenza Borin,
• Andrea Castelli,
• Roberto Cairoli,
• Wilma Barcellini,
• Alfredo Molteni,
• Bruno Fattizzo

Affiliations

Marta Riva

1 Department of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Alessandro Bosi

2 Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Lorenzo Rizzo

1 Department of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Federico Mazzon

1 Department of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Silvia Ferrari

4 Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

Federico Lussana

4 Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

Lorenza Borin

5 Department of Hematology, San Gerardo Hospital, Monza, Italy

Andrea Castelli

6 Haematology, ASL Biella, Italy

Roberto Cairoli

1 Department of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Wilma Barcellini

2 Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Alfredo Molteni

7 Haematology, ASST Cremona, Italy

Bruno Fattizzo

2 Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy